2015
DOI: 10.1093/bja/aeu374
|View full text |Cite
|
Sign up to set email alerts
|

Effect of flumazenil on diaphragm electrical activation during weaning from mechanical ventilation after acute respiratory distress syndrome

Abstract: During weaning from mechanical ventilation, the diaphragmatic contribution to the breathing process may be reduced by residual midazolam-induced ventilatory depression. The increased EAdi with reversal of residual sedation was associated with a proportional increase in VT. These findings should be considered by the attending physician when interpreting daily EAdi and VT changes during weaning from mechanical ventilation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
14
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 17 publications
(14 citation statements)
references
References 29 publications
0
14
0
Order By: Relevance
“…Additionally, respiratory drive affects the pathophysiology and clinical outcome of ARDS (Spinelli et al, 2020). Dexmedetomidine was not found to affect the respiratory rate or gas exchange in ICU patients compared to a placebo (Venn et al, 2000) and did not affect the hypercapnic ventilatory response in healthy volunteers (Hsu et al, 2004); conversely, sedation with midazolam or propofol might suppress the respiratory drive in patients on mechanical ventilation (Migliari et al, 2009;Rozé et al, 2015). Another biological rationale for the potential benefit of dexmedetomidine is based on the experimental evidence of protective effects against neuronal, myocardial, and renal injury (Si et al, 2014;Ren et al, 2016), the reduction in the levels of inflammatory mediators after cardiopulmonary bypass; and the reduced mortality rates observed in animal models (Taniguchi et al, 2004;Ueki et al, 2014).…”
Section: Discussionmentioning
confidence: 99%
“…Additionally, respiratory drive affects the pathophysiology and clinical outcome of ARDS (Spinelli et al, 2020). Dexmedetomidine was not found to affect the respiratory rate or gas exchange in ICU patients compared to a placebo (Venn et al, 2000) and did not affect the hypercapnic ventilatory response in healthy volunteers (Hsu et al, 2004); conversely, sedation with midazolam or propofol might suppress the respiratory drive in patients on mechanical ventilation (Migliari et al, 2009;Rozé et al, 2015). Another biological rationale for the potential benefit of dexmedetomidine is based on the experimental evidence of protective effects against neuronal, myocardial, and renal injury (Si et al, 2014;Ren et al, 2016), the reduction in the levels of inflammatory mediators after cardiopulmonary bypass; and the reduced mortality rates observed in animal models (Taniguchi et al, 2004;Ueki et al, 2014).…”
Section: Discussionmentioning
confidence: 99%
“…Sedation exerts a well-known inhibitory effect on diaphragmatic contractility [12,13]. Diaphragmatic activity may be jeopardised by a residual sedation, especially in the early weaning period [14]. Last, TFdi was negatively but not significantly associated with early ICU treatments (neuromuscular blockers or vasopressor use before inclusion) and complications (ventilator-associated pneumonia and prolonged ventilation), which may be risk factors for diaphragmatic atrophy and weakness [15].…”
mentioning
confidence: 99%
“…The anesthetic agent, sodium midazolam, can affect respiratory depression. 13 However, in the current study, both MV and control animals were anesthetized with sodium midazolam, thus comparisons between the groups are valid. Furthermore, the drinking reflex was preserved, indicating that there was no or minimal depression of diaphragm activity due to the drug.…”
Section: Discussionmentioning
confidence: 95%